From mitochondrial function to neuroprotection—an emerging role for methylene blue

D Tucker, Y Lu, Q Zhang - Molecular neurobiology, 2018 - Springer
Methylene blue (MB) is a well-established drug with a long history of use, owing to its
diverse range of use and its minimal side effect profile. MB has been used classically for the …

A review of trazodone use in psychiatric and medical conditions

HR Khouzam - Postgraduate medicine, 2017 - Taylor & Francis
Trazodone is an antidepressant that is FDA-approved for the treatment of depression. It has
been used by mental health and primary care providers for the treatment of multiple …

Management of severe arterial hypertension associated with serotonin syndrome: a case report analysis based on systematic review techniques

M Ott, JK Mannchen, F Jamshidi… - Therapeutic advances …, 2019 - journals.sagepub.com
Serotonin syndrome is thought to arise from serotonin excess. In many cases, symptoms are
mild and self-limiting. But serotonin syndrome can become life threatening, when …

Postanesthesia care for the elderly patient

PS Garcia, EW Duggan, IL McCullough, SC Lee… - Clinical …, 2015 - Elsevier
Purpose As the general population lives longer, the perioperative physician is more likely to
encounter disease states that increase in incidence in an aging population. This review …

Serotonin toxicity and urinary analgesics: a case report and systematic literature review of methylene blue-induced serotonin syndrome

ZD Zuschlag, MW Warren, SK Schultz - Psychosomatics, 2018 - Elsevier
Background Serotonin syndrome (SS) is a potentially serious side effect of serotonergic
drugs. Cases of SS have been reported from the administration of methylene blue (MB), an …

The blue coma: the role of methylene blue in unexplained coma after cardiac surgery

EA Martino, D Winterton, P Nardelli, L Pasin… - … of Cardiothoracic and …, 2016 - Elsevier
Objectives Methylene blue commonly is used as a dye or an antidote, but also can be used
off label as a vasopressor. Serotonin toxicity is a potentially lethal and often misdiagnosed …

Vasoplegic shock treated with methylene blue complicated by severe serotonin syndrome

BS Chan, T Becker, AL Chiew, AM Abdalla… - Journal of Medical …, 2018 - Springer
Introduction Management of severe vasoplegic shock in overdose can be very challenging.
We describe a case of severe refractory vasodilatory shock in poisoning where methylene …

Serotonin syndrome after methylene blue administration during cardiac surgery: a case report and review

T Wolvetang, R Janse, M Ter Horst - Journal of cardiothoracic and …, 2016 - jcvaonline.com
DISCUSSION The Hunter criteria suggest serotonin toxicity in the presence of a serotonergic
agent—paroxetine and quetiapine in this patient—and 1 of the 5 following clusters of …

[HTML][HTML] Perioperative diagnosis and treatment of serotonin syndrome following administration of methylene blue

J Francescangeli, S Vaida… - The American Journal of …, 2016 - ncbi.nlm.nih.gov
Objective: Unusual clinical course Background: Serotonin syndrome (SS) involves
serotonergic hyperactivity caused by excessive activation of 5-HT2A receptors. As the use of …

Methylene blue–induced serotonin syndrome after left ventricular assist device implantation: a case report and literature review

LED Schumacher, V Blumer, SV Chaparro - The Journal of thoracic and …, 2017 - jtcvs.org
Discussion This article presents the first case of serotonin syndrome after a routine LVAD
implantation and is the fourteenth case of serotonin syndrome in cardiology literature (Video …